Jun 30, 2024

P3 Health Q2 2024 Earnings Report

P3 Health's financial performance increased in revenue but decreased in profitability during the second quarter of 2024.

Key Takeaways

P3 Health Partners reported a revenue increase of 15% compared to the prior year, driven by growth in capitated revenue. However, gross profit and medical margin decreased, leading to a net loss. The company is focusing on initiatives to enhance capabilities and achieve sustainable profitability.

Total revenue increased by 15% to $379.2 million compared to the second quarter of the prior year.

Capitated revenue increased by 15% to $374.3 million compared to the second quarter of the prior year.

Gross profit was $14.0 million, compared to $26.8 million in the prior year.

Net loss was $28.8 million, compared to a net loss of $27.6 million in the second quarter of the prior year.

Total Revenue
$379M
Previous year: $329M
+15.2%
EPS
-$0.15
Previous year: -$0.09
+66.7%
Gross Profit
-$7.71M
Previous year: $26.8M
-128.7%
Cash and Equivalents
$78.2M
Previous year: $59.9M
+30.5%
Free Cash Flow
-$10.2M
Previous year: -$30M
-65.9%
Total Assets
$893M
Previous year: $909M
-1.8%

P3 Health

P3 Health

P3 Health Revenue by Segment

Forward Guidance

P3 Health Partners provided financial guidance for the year ending December 31, 2024.

Positive Outlook

  • Total Revenues (in millions): $1,450 - $1,550
  • Medical margin (in millions): $230 - $250
  • Medical margin PMPM: $165 - $175
  • Adjusted EBITDA (in millions): $20 - $40

Revenue & Expenses

Visualization of income flow from segment revenue to net income